Stoke Therapeutics, Inc.

The current price of STOK is 11.72 USD — it has decreased by 5.86% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Stoke Therapeutics, Inc. stocks are traded under the ticker STOK.

Stoke Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Stoke Therapeutics, Inc. has a max estimate of 35.00 USD and a min estimate of 14.00 USD.

STOK earnings for the last quarter are −0.55 USD whereas the estimation was −0.63 USD which accounts for 13.04% surprise. Estimated earnings for the next quarter are −0.61 USD. See more details about Stoke Therapeutics, Inc. earnings.

Yes, you can track Stoke Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, STOK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stoke Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

STOK reached its all-time high on Jan 20, 2021 with the price of 71.58 USD, and its all-time low was 3.35 USD and was reached on Oct 27, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 110.00 employees. See our rating of the largest employees — is Stoke Therapeutics, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Stoke Therapeutics, Inc. EBITDA is ‪−110.04 M‬ USD, and current EBITDA margin is ‪−1.25 K‬%. See more stats in Stoke Therapeutics, Inc. financial statements.